Daniel Barber, President and CEO at Aquestive Therapeutics, Inc. (AQST), sold 182,686 shares at $6.03 ($1.1M) on 2025-09-26, disclosed to the SEC on 2025-09-29.
Scheduled sale ($1.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.03 | 91,343 | $551K | 50.0% |
| 2 | $6.03 | 91,343 | $551K | 50.0% |
| Total | $6.03 avg | 182,686 | $1.1M | 100% |
| Filing → |
| AQST | SELL | 2026-07-17 | $100K | — | Filing → |
| AQST | SELL | 2026-06-16 | $104K | — | Filing → |
| AQST | SELL | 2026-05-18 | $35K | — | Filing → |